BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8965473)

  • 1. [Tyndallometry for follow-up of iodine-125 brachytherapy of uveal malignant melanomas. Report of 2 patients].
    Nguyen NX; Küchle M; Strunk W
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):25-30. PubMed ID: 8965473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iodine-125-brachytherapy of malignant choroid melanoma. II: Long-term functional outcome].
    Kreissig I; Rose D; Simader E
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):7-12. PubMed ID: 8965481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients.
    Finger PT; Chin KJ; Duvall G;
    Ophthalmology; 2009 Apr; 116(4):790-6, 796.e1. PubMed ID: 19243829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
    Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
    Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laser-tyndallometry in eyes with acute retinal necrosis syndrome. Erlanger Laser-tyndallometry study group].
    Nguyen NX; Amann T; Küchle M
    Klin Monbl Augenheilkd; 1998 Oct; 213(4):197-200. PubMed ID: 9848063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
    Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
    Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT; Berson A; Szechter A
    Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant transformation of a choroidal nevus 6 years after brachytherapy of a non-contiguous choroidal melanoma - a case report and review of literature].
    Spraul CW; Gäckle HC; Lang GK
    Klin Monbl Augenheilkd; 2001 Sep; 218(9):626-31. PubMed ID: 11590472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
    Stoffelns BM; Kutzner J; Jochem T
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Ophthalmology; 2010 May; 117(5):1013-23. PubMed ID: 20097428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of central vision and macular structure in patients undergoing iodine-125 brachytherapy for ciliochoroidal melanoma.
    Oliver SC; Young TA; Kobe LH; Leu MY; Lee SP; Chun MW; Straatsma BR
    Am J Clin Oncol; 2008 Oct; 31(5):488-92. PubMed ID: 18838887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular complications following I-125 brachytherapy for choroidal melanoma.
    Wen JC; Oliver SC; McCannel TA
    Eye (Lond); 2009 Jun; 23(6):1254-68. PubMed ID: 19265865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
    Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
    Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
    Sobrin L; Schiffman JC; Markoe AM; Murray TG
    Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of radiation retinopathy following plaque brachytherapy for choroidal melanoma.
    Wen JC; McCannel TA
    Curr Opin Ophthalmol; 2009 May; 20(3):200-4. PubMed ID: 19349865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective nonrandomised analysis of "Sandwich Therapy" for malignant melanoma of the choroid].
    Stoffelns BM; Kutzner J; Schöpfer K; Frising M
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):211-5. PubMed ID: 12022003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planned combined I-125 plaque irradiation and indirect ophthalmoscope laser therapy for choroidal malignant melanoma.
    Augsburger JJ; Mullen D; Kleineidam M
    Ophthalmic Surg; 1993 Feb; 24(2):76-81. PubMed ID: 8446358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.